BIOMARKER:

AKT1 mutation

Entrez ID:

Related biomarkers:

‹

›

AKT1 mutation AKT1 mutation	Triple Negative Breast Cancer Triple Negative Breast Cancer	GDC-0068 Sensitive: B - Late Trials
AKT1 mutation AKT1 mutation	Colorectal Cancer CRC	atezolizumab + cobimetinib Sensitive: B - Late Trials
AKT1 mutation AKT1 mutation	Breast Cancer Breast Cancer	ribociclib Sensitive: B - Late Trials
AKT1 mutation AKT1 mutation	Endometrial Cancer Endometrial Cancer	temsirolimus Sensitive: C3 – Early Trials
AKT1 mutation AKT1 mutation	Prostate Cancer Prostate Cancer	enzalutamide + AZD5363 Sensitive: D – Preclinical

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

Associations